Remediation options to reduce bioaccessible and bioavailable lead and arsenic at a smelter impacted site - consideration of treatment efficacy
Environmental Pollution · 2024
DOI: 10.1016/j.envpol.2023.122881 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Pollution, 2024. Verfasst von Dileepa Alankarage und 5 weiteren Autor:innen. Beteiligte Einrichtung: Future Industries Institute, STEM, University of South Australia, SA, Australia. Electronic address: aladm001@mymail.unisa.edu.au. Hauptthemen laut MEDLINE: Arsenic, Soil Pollutants. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural EPA, University of South Australia.
Abstract (Originalsprache)
In this study, smelter contaminated soil was treated with various soil amendments (ferric sulfate [Fe2(SO4)3], triple superphosphate [TSP] and biochar) to determine their efficacy in immobilizing soil lead (Pb) and arsenic (As). In soils incubated with ferric sulfate (0.6M), gastric phase Pb bioaccessibility was reduced from 1939 ± 17 mg kg-1 to 245 ± 4.7 mg kg-1, while intestinal phase bioaccessibility was reduced from 194 ± 25 mg kg-1 to 11.9 ± 3.5 mg kg-1, driven by the formation of plumbojarosite. In TSP treated soils, there were minor reductions in gastric phase Pb bioaccessibility (to 1631 ± 14 mg kg-1) at the highest TSP concentration (6000 mg kg-1) although greater reductions were observed in the intestinal phase, with bioaccessibility reduced to 9.3 ± 2.2 mg kg-1. Speciation analysis showed that this was primarily driven by the formation of chloropyromorphite in the intestinal phase following Pb and phosphate solubilization in the low pH gastric fluid. At the highest concentration (10% w/w), biochar treated soils showed negligible decreases in Pb bioaccessibility in both gastric and intestinal phases. Validation of bioaccessibility outcomes using an in vivo mouse assay led to similar results, with treatment effect ratios (TER) of 0.20 ± 0.01, 0.76 ± 0.11 and 1.03 ± 0.10 for ferric sulfate (0.6M), TSP (6000 mg kg-1) and biochar (10% w/w) treatments. Results of in vitro and in vivo assays showed that only ferric sulfate treatments were able to significantly reduce As bioaccessibility and bioavailability with TER at the highest application of 0.06 ± 0.00 and 0.14 ± 0.04 respectively. This study highlights the potential application of ferric sulfate treatment for the immobilization of Pb and As in co-contaminated soils.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Future Industries Institute, STEM, University of South Australia, SA, Australia. Electronic address: aladm001@mymail.unisa.edu.au.
- United States Environmental Protection Agency, National Risk Management Research Laboratory, Land Remediation and Pollution Control Division, Cincinnati, OH, USA.
- South Australian Health and Medical Research Institute, Preclinical, Imaging and Research Laboratories, Adelaide, 5086, Australia.
- Future Industries Institute, STEM, University of South Australia, SA, Australia.
Förderung
- Intramural EPA
- University of South Australia
Zitieren
APA
Alankarage, D., Betts, A., Scheckel, K. G., Herde, C., Cavallaro, M., & Juhasz, A. L. (2024). Remediation options to reduce bioaccessible and bioavailable lead and arsenic at a smelter impacted site - consideration of treatment efficacy. Environmental Pollution. https://doi.org/10.1016/j.envpol.2023.122881
Vancouver
Alankarage D, Betts A, Scheckel KG, Herde C, Cavallaro M, Juhasz AL. Remediation options to reduce bioaccessible and bioavailable lead and arsenic at a smelter impacted site - consideration of treatment efficacy. Environmental Pollution. 2024. doi:10.1016/j.envpol.2023.122881
BibTeX
@article{Alankarage2024,
author = {Alankarage, Dileepa and Betts, Aaron and Scheckel, Kirk G and Herde, Carina and Cavallaro, Michelle and Juhasz, Albert L},
title = {Remediation options to reduce bioaccessible and bioavailable lead and arsenic at a smelter impacted site - consideration of treatment efficacy},
journal = {Environmental Pollution},
year = {2024},
doi = {10.1016/j.envpol.2023.122881}
}
EUVIMED